Is It Time to Rethink User Fees?
In an article titled “A Bipartisan Case Against US FDA User Fees?” published in the Pink Sheet on July 11, 2022, Michael McCaughan discusses two of the no votes from senators on reauthorization of the user fee program. McCaughan writes that Senators Richard Burr and Bernie Sanders “expressed concern that the increasing fees contribute to […]
